Proxy

Triple Flag Provides Update on Combination with Maverix

Retrieved on: 
Friday, January 13, 2023
Mining, Minerals, Natural Resources, EDGAR, Person, TSX, NYSE, Ontario Superior Court of Justice, Arrangement, File, SEDAR, Minority, Flag, Canada Business Corporations Act, Acquisition, Proxy, Security (finance), MaveriX

Triple Flag Precious Metals Corp. (with its subsidiaries, “Triple Flag” or the “Company”) (TSX: TFPM, NYSE: TFPM) is pleased to provide an update on its previously announced acquisition of Maverix Metals Inc. (“Maverix”) by way of a plan of arrangement under the Canada Business Corporations Act (the “Arrangement”).

Key Points: 
  • Triple Flag Precious Metals Corp. (with its subsidiaries, “Triple Flag” or the “Company”) (TSX: TFPM, NYSE: TFPM) is pleased to provide an update on its previously announced acquisition of Maverix Metals Inc. (“Maverix”) by way of a plan of arrangement under the Canada Business Corporations Act (the “Arrangement”).
  • Votes at the Meeting were taken by poll online, and proxies were received by Maverix prior to the Meeting.
  • Triple Flag also reports that the Canadian Competition Bureau has issued a “no action” letter clearing the Arrangement under Canadian competition law.
  • Triple Flag and Maverix are working towards an expeditious closing of the Arrangement slated to occur prior to the end of January.

LanzaTech Announces AMCI Acquisition Corp. II Shareholder Meeting For Approval Of Business Combination Scheduled For February 1, 2023

Retrieved on: 
Thursday, January 12, 2023
Other Manufacturing, Environment, Environmental Health, Manufacturing, Alternative Energy, Sustainability, Green Technology, Energy, Recycling, Form, Security (finance), Register, Date, Person, Business architecture, Special, Proxy, Proxy statement, Shareholder, CCT, Eastern Time Zone, Registration statement, Carbon, Partnership, Acceleration, Aviation biofuel, Prospectus

Dr. Jennifer Holmgren, Chief Executive Officer of LanzaTech, said “We are thrilled to reach this important milestone in our journey towards becoming a public company via our partnership with AMCI.

Key Points: 
  • Dr. Jennifer Holmgren, Chief Executive Officer of LanzaTech, said “We are thrilled to reach this important milestone in our journey towards becoming a public company via our partnership with AMCI.
  • AMCI urges its investors, stockholders and other interested persons to read the definitive proxy statement/prospectus, as well as other documents filed by AMCI with the SEC, because these documents contain important information about AMCI, LanzaTech and the Business Combination.
  • AMCI has mailed the definitive proxy statement/prospectus to its stockholders of record as of the Record Date for voting on the proposed Business Combination.
  • Stockholders, potential investors and other interested persons should read the definitive proxy statement/prospectus carefully before making any voting or investment decisions.

Decarbonization Plus Acquisition Corporation IV Reminds Shareholders to Vote in Favor of Proposed Business Combination with Hammerhead

Retrieved on: 
Thursday, January 12, 2023
Online, Extraordinary general meeting, Sports Properties Acquisition Corporation, Additional member system, Security (finance), Cyprus Securities and Exchange Commission, Date, Internet, CONTROL, FORM, Special, Hammerhead, Proxy, High, Control, Eastern Time Zone, Acquisition, Proxy statement, Holding company

MENLO PARK, Calif., Jan. 12, 2023 /PRNewswire/ -- Decarbonization Plus Acquisition Corporation IV (NASDAQ: DCRD) ("DCRD"), a publicly-traded special purpose acquisition company, reminds its shareholders to vote in favor of the previously announced business combination with Hammerhead Resources Inc. ("Hammerhead"), a Calgary–based energy company.

Key Points: 
  • MENLO PARK, Calif., Jan. 12, 2023 /PRNewswire/ -- Decarbonization Plus Acquisition Corporation IV (NASDAQ: DCRD) ("DCRD"), a publicly-traded special purpose acquisition company, reminds its shareholders to vote in favor of the previously announced business combination with Hammerhead Resources Inc. ("Hammerhead"), a Calgary–based energy company.
  • The Extraordinary General Meeting to approve the proposed business combination and related matters is scheduled to be held on January 23, 2023 at 10:00 a.m. Eastern Time.
  • Vote at the Meeting: If you plan to attend the Extraordinary General Meeting, you will need your voting control number to vote electronically at the Extraordinary General Meeting.
  • You will need this in order to vote or to attend the Extraordinary General Meeting.

VEON provides update on voting on Scheme

Retrieved on: 
Tuesday, January 17, 2023
Bermuda, First Nations in Ontario, Union, United Kingdom, NSD, VEON, Belarus, Creditor, Explanation, Euronext Amsterdam, Personal Information Agent, Intermediary, DTC, Note, Constitutional amendment, Account, Russia, Information, Instruction, Republic, United Nations, Scheme, ISIN, Auction, Cryptocurrency, Security (finance), Proxy, Clearstream

Amsterdam, Netherlands, 17 January 2023: VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON) (“VEON” or, together with its subsidiaries, the “Group”), a global digital operator that provides converged connectivity and online services, and its subsidiary VEON Holdings B.V. (the “Company”) refers to its prior announcements in relating to the Company’s proposed scheme of arrangement (the “Scheme”) in respect of the 5.95% notes due February 2023 and 7.25% notes due April 2023 issued by the Company (together, the “2023 Notes”).

Key Points: 
  • Amsterdam, Netherlands, 17 January 2023: VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON) (“VEON” or, together with its subsidiaries, the “Group”), a global digital operator that provides converged connectivity and online services, and its subsidiary VEON Holdings B.V. (the “Company”) refers to its prior announcements in relating to the Company’s proposed scheme of arrangement (the “Scheme”) in respect of the 5.95% notes due February 2023 and 7.25% notes due April 2023 issued by the Company (together, the “2023 Notes”).
  • The Company has today provided an update on voting on the Scheme.
  • The Voting and Proxy Form is available on the Scheme Website and may be submitted by completing the electronic form on the Scheme Website or by submitting a pdf of the completed Voting and Proxy Form to the Information Agent at [email protected].
  • For the avoidance of doubt, a Scheme Creditor shall not be a Sanctions Disqualified Person solely because it holds its 2023 Notes through the NSD.

STOCKHOLDER ALERT – Andrews & Springer LLC Announces That A Securities Action Has Been Filed Against KnowBe4, Inc. For Securities Violations - KNBE

Retrieved on: 
Monday, January 16, 2023
Vista, District court, Cowen Inc., Proxy, Mergers and acquisitions, Vista Equity Partners, Court, Complaint, KNBE, Investment, Security (finance)

A copy of the complaint is available from the Court or from Andrews & Springer LLC.

Key Points: 
  • A copy of the complaint is available from the Court or from Andrews & Springer LLC.
  • You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc , Twitter – www.twitter.com/AndrewsSpringer or Facebook - www.facebook.com/AndrewsSpringer for future updates.
  • A KnowBe4 shareholder represented by another law firm has filed a complaint against KnowBe4 for federal securities violations.
  • Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty or corporate misconduct.

CTXS, GAIA & DAKT Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate

Retrieved on: 
Monday, January 16, 2023
Vista, TIBCO, Tax, Complaint, Proxy, Defendant, TIBCO Software, Mergers and acquisitions, Vista Equity Partners, Software, Court, Elliot, Daktronics, Citrix Systems

NEW YORK, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

Key Points: 
  • NEW YORK, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
  • You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

argenx Announces Extraordinary General Meeting of Shareholders on February 27, 2023 to Appoint Steve Krognes as Non-Executive Director

Retrieved on: 
Monday, January 16, 2023
Degenerative disease, Euronext, Audit, Person, Proxy, Management, Amsterdam Airport Schiphol

The shareholders and all other persons with meeting rights are invited to attend the extraordinary general meeting of shareholders.

Key Points: 
  • The shareholders and all other persons with meeting rights are invited to attend the extraordinary general meeting of shareholders.
  • The sole voting item on the agenda will be the proposed appointment of Mr. Steve Krognes as non-executive director and Chair of the Audit and Compliance Committee of the Company’s Board of Directors.
  • The full agenda for the meeting, as well as all ancillary documents relevant for the meeting are available via the argenx website and are also available for inspection at the argenx offices.
  • argenx would like to encourage shareholders to use the voting by (electronic) proxy option as referred to in the convocation.

ForgeRock, Inc. (FORG) Shareholder Alert: Robbins LLP Reminds Investors it is Investigating the Acquisition of ForgeRock, Inc. by Thoma Bravo

Retrieved on: 
Friday, January 13, 2023
Steps, SAN, Thoma Bravo, Proxy, Acquisition, Proxy statement, ForgeRock, NYSE, Bank

SAN DIEGO, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors it is investigating the acquisition of ForgeRock, Inc. (NYSE: FORG) by Thoma Bravo.

Key Points: 
  • SAN DIEGO, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors it is investigating the acquisition of ForgeRock, Inc. (NYSE: FORG) by Thoma Bravo.
  • Under the terms of the agreement, ForgeRock stockholders will receive $23.25 in cash for each share of ForgeRock common stock owned.
  • In October 2022, ForgeRock announced a deal to be acquired by private-equity firm Thoma Bravo.
  • According to the Proxy Statement, ForgeRock's board approved a merger agreement with Thoma Bravo for $23.25 per share in cash.

VEON issues amended Scheme

Retrieved on: 
Wednesday, January 11, 2023
United Kingdom, Euronext Amsterdam, Put, Personal Information Agent, Deed, Trustee, Information, Deed poll, Union, Element, Standstill period, Intermediary, Eligibility, Chair, DTC, VEON, Moelis & Company, Republic, Section 4, Appendix, Part, NSD, PJSC VimpelCom, Belarus, Creditor, Explanation, LLP, Note, Russia, United Nations, USD, Exercise, Bermuda, First Nations in Ontario, PJSC, Calendar, Constitutional amendment, Court, Cryptocurrency, Audit, Security (finance), Proxy, Scheme

Amsterdam, Netherlands, 11 January 2023 23:50 CET: VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON) (“VEON” or, together with its subsidiaries, the “Group”), a global digital operator that provides converged connectivity and online services, and its subsidiary VEON Holdings B.V. (the “Company”) refer to the announcement dated 21 December 2022 relating to the Company’s proposed scheme of arrangement (the “Scheme”) in respect of the 5.95% notes due February 2023 and 7.25% notes due April 2023 issued by the Company (together, the “2023 Notes”), and in particular relating to the convening of a single meeting of Scheme Creditors to be held on 24 January 2023 (the “Scheme Meeting”).

Key Points: 
  • Amsterdam, Netherlands, 11 January 2023 23:50 CET: VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON) (“VEON” or, together with its subsidiaries, the “Group”), a global digital operator that provides converged connectivity and online services, and its subsidiary VEON Holdings B.V. (the “Company”) refer to the announcement dated 21 December 2022 relating to the Company’s proposed scheme of arrangement (the “Scheme”) in respect of the 5.95% notes due February 2023 and 7.25% notes due April 2023 issued by the Company (together, the “2023 Notes”), and in particular relating to the convening of a single meeting of Scheme Creditors to be held on 24 January 2023 (the “Scheme Meeting”).
  • The Company has today issued an amended Explanatory Statement in connection with the Scheme, which amends the terms of the Scheme (the “Amended Explanatory Statement”).
  • Following feedback from certain of the 2023 Noteholders, the Company has today informed the Scheme Creditors, by the Amended Explanatory Statement, that it has amended the terms of the proposal set out in the Scheme.
  • Scheme Creditors or, if a corporation, their representative, or the proxy attending the Scheme Meeting on their behalf will be required to verify their entitlement to attend the Scheme Meeting as a Scheme Creditor before they will be granted access to the Scheme Meeting by a representative of the Information Agent.

First Wave BioPharma Announces Adjournment of Special Meeting

Retrieved on: 
Monday, January 9, 2023
EST, Communication, Special, First wave, BOCA, Proxy, Holding company, Shareholder

BOCA RATON, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it has adjourned its Special Meeting of Stockholders (the “Special Meeting”) in order to provide stockholders additional time within which to vote on all proposals.

Key Points: 
  • BOCA RATON, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it has adjourned its Special Meeting of Stockholders (the “Special Meeting”) in order to provide stockholders additional time within which to vote on all proposals.
  • Therefore, the Company adjourned the Special Meeting.
  • The adjourned meeting will be held at 9:00 a.m. EST on January 13, 2023 at the following url: www.virtualshareholdermeeting.com/FWBI2023SM.
  • Special Meeting of Stockholders of First Wave BioPharma, Inc.